Fig. 7
From: EZH2 K63-polyubiquitination affecting migration in extranodal natural killer/T-cell lymphoma
Dexamethasone effectively targets the TRIP12-EZH2 cascade. (A, B) Immunoblots showing change of TRIP12 and EZH2 level upon dexamethasone treatment with indicated concentrations in NK92 (A) and YT (B). N = 3 individual experiments and representative images are shown. C Relative viability of ENKTL cells upon dexamethasone treatment for 48 h. Cell Counting Kit-8 assay was used to measure cell viability